Dactolisib Tosylate (BEZ235 Tosylate) 作为一种有效的PI3K/mTOR双重激酶抑制剂，并且能够同时抑制mTORC1和mTORC2复合物的功能。

/

2~8℃避光保存，有效期3年。

[1] Maira SM, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C, Brachmann S, Chène P, De Pover A, Schoemaker K, Fabbro D, Gabriel D, Simonen M, Murphy L, Finan P, Sellers W, García-Echeverría C. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther. 2008 Jul;7(7):1851-63. doi: 10.1158/1535-7163.MCT-08-0017. Epub 2008 Jul 7. PMID: 18606717.